Charles, L. and Sawyers, C. L.: Chronic myeloid leukemia. N. Engl. J. Med.340(17): 1330-1340.1999.
O’Brien. S. G., Guilhot, F., Larson, R. A., et al.: Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N. Engl. J. Med.348(11): 994-1004, 2003.
Yokota, A. and Kimura. S.: Novel agents to override imatinib resistance mechanisms. Drug Der. Res.69(7): 398-406, 2008.
Kimura, S., Naito, H., Segawa, H., et al.: NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib resistant leukemia. Blood 106(12): 3948-3954, 2005.